New CEO to Swedish Tillotts Pharma

The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.

By Sophia Carlsson

January 12, 2009 12:00 AM

The Swiss biopharmaceutical

company Tillotts Pharma has recently entered Sweden, by opening an office in Stockholm under private management. Through the creation of this new Swedish company the company has appointed Mattias Norrman as CEO. Mattias Norrman has previously worked at Bayer Scandinavia, in a chief position.

Tillotts Pharma is focused

on gastroenterology and stand behind the drug Asacol, used against intestine inflammations. The drug’s turnover in the Nordic countries is almost SEK 170 million. The new Nordic Tillotts Pharma will continue to focus on Asacol.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.